Evidence map›Paper›PMID 40535694›Full record

ArticleAmerican journal of translational research2025

Quantum dual-branch neural networks with transfer learning for early detection of skin cancer.

Yuyang Sun, Xing Deng, Haijian Shao

Abstract read
In one paragraph

Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yuyang SunSchool of Computer, Jiangsu University of Science and Technology Zhenjiang 212100, Jiangsu, China.
Xing DengSchool of Computer, Jiangsu University of Science and Technology Zhenjiang 212100, Jiangsu, China.
Haijian ShaoSchool of Computer, Jiangsu University of Science and Technology Zhenjiang 212100, Jiangsu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAccurate classification of skin cancer is critical for early detection and timely treatment, significantly improving patient survival rates. While quantum neural networks combined with transfer learning show promise in medical image analysis, quantum noise remains a major challenge, compromising the stability and reliability of these systems. This study aims to address this limitation by developing a robust quantum-based framework for skin cancer classification.

methodsWe propose a Quantum Dual-Branch Neural Network (QDBNN) that employs two independently trained network branches without shared weights. Dual-modal features are fused at the fully connected layer, and a Variational Quantum Classifier (VQC) is utilized for final classification. The model is evaluated on two datasets: the multiclass HAM10000 and the binary Malignant vs. Benign dataset.

resultsQDBNN achieved state-of-the-art accuracies of 93.6% on HAM10000 and 93.5% on the Malignant vs. Benign dataset, outperforming classical and quantum transfer learning baselines. The dual-branch architecture and weighted feature fusion demonstrated enhanced robustness against quantum noise while improving generalization.

conclusionQDBNN effectively mitigates quantum noise interference and leverages quantum-classical hybrid advantages for skin cancer classification. Its success highlights the potential of quantum-inspired architectures in medical imaging, offering a pathway toward clinically deployable tools for early diagnosis. Future work will focus on hardware optimization and scalability to larger datasets.

Indexed as

deep learningQuantum computingskin cancer diagnosis

Identifiers

PMID40535694
PMCPMC12170388

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.